PE firm Advent acquires 50.1% stake in Suven Pharma at Rs 495/share, to make open offer for additional 26% stake

Advent also announced the new Board of Directors and management team for Suven Pharma, including Sudhir Kumar Singh as CEO

Related Keywords

India ,Venkateswarlu Jasti ,V Prasada Raju ,Suven Lifesciences ,Suven Pharma ,Sudhir Kumar Singh ,Abhijit Mukherjee ,Pankaj Patwari ,Shweta Jalan ,Jj Asia Pacific ,Annaswamy Vaidheesh ,Prasada Raju ,Stefan Stoffel ,Aragen Life Sciences ,Partner At Advent International ,Advent International Corporation ,Organization Of Pharmaceutical Producers India ,Partners Lps ,Suven Pharmaceuticals Ltd ,Cohance Life Sciences ,Berhyanda Ltd ,Granules India Ltd ,Suven Pharmaceuticals ,Advisory Council ,Advent International ,Executive Chairman ,Managing Director ,Chief Executive Officer ,Chairman Annaswamy Vaidheesh ,Pharmaceutical Producers ,Granules India ,Managing Partner ,Cyprus Based Berhyanda Ltd ,Advent Funds ,Limited Partners ,International Corporation ,Private Equity ,Dmo ,